Biocel, created in 2000 (United States), from 274 sister brands and 2617 competing brands. Biocel is owned by Agilent Technologies, Inc., listed on the stock exchange of New York The sector of Biocel is Medical Diagnostics & Research.
Investment simulator :
Portfolio valuation
Agilent Technologies, Inc.
(Biocel)
over 5 years*
USD 243.96